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(40-cyanobiphenyl-4-ylimino)methyl)phenoxy)alkanoate (3a–j) have been synthesized and charac-
terized by IR, NMR and mass spectral studies. In vitro antioxidant activities of these compounds
were evaluated against super oxide anion radical, nitric oxide radical, DPPH radical and hydrogen
peroxide and were compared with standard natural antioxidant, ascorbic acid. Our results reveal
that these compounds exhibit excellent radical scavenging activities.
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Currently, numerous investigations are ongoing into the inter-
action of free radicals with biological systems such as lipids,
DNA and protein. The free radicals are responsible for many
diseases such as neurodegenerative diseases, atherosclerosis,
age-related diseases, rheumatoid arthritis, cancer initiation
and tumor [2,18,33]. It is necessary to keep a proper level of
natural antioxidants such as vitamin C, vitamin E and gluta-
thione in biological system in order to avoid serious health
problems [11,16,14,27]. All of these health problems are caused
by the reaction of reactive oxygen species (ROS) and reactive
nitrogen species (RNS), commonly known as reactive species(RSs) [5,17]. There are three ways by which RSs are formed:
(i) metal catalyzed reactions, (ii) presence of pollutants in the
atmosphere, (iii) irradiation by UV light, X-ray and gamma
rays [8].
Antioxidants are generally hydrogen donors or electron
donors to the reactive site in neutralizing free radicals
[13,20]. The scavenging activity of different organic com-
pounds can be assessed using DPPH, hydrogen peroxide,
superoxide anion radical, and ABTS+. It has been already
reported that many organic molecules act as very good antiox-
idants, thus it is important to understand the mode of action
and efﬁciency of these antioxidants. There are large numbers
of natural and synthetic antioxidants which have been
explored, and their antioxidant capacity has been assessed by
different methods [26].
Realizing the effects of free radicals, it is of paramount sig-
niﬁcance to develop very efﬁcient antioxidants to prevent dam-
age caused by free radicals. Our group is interested in
synthesizing organic new Schiff base molecule to investigate
the antioxidants’ property by employing superoxide anion rad-
ical, nitric oxide radical, DPPH radical and hydrogen perox-
ide. Schiff base has a similar structure of trans stilbene and
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derivatives with aniline. Resveratrol is a well-characterized
antioxidant found in grapes. It has been reported that the only
structural difference between resveratrol and Schiff base is
C‚N and C‚C [34]. The presence of C‚N linkage in Schiff
base is very important for biological activity, such as antibac-
terial, antifungal, anticancer, antioxidant and diuretic activi-
ties. These compounds also have applications in food
chemistry, dye industry, agro chemical and pharmaceuticals
[1,15,35,9,25,30,36]. Some selected examples are given in
Fig. 1. [1,21,35]. These Schiff bases can be used for further bio-
logical studies such as antimicrobial [28], antifungal [32] and
antitumor [23].
Steroids play a very important role in human metabolism
by acting as an essential part of the cell membranes (choles-
terol) or hormones. Addition or modiﬁcation in steroidal skel-
eton would lead to changes in their biological activities
[3,24,31]. Selected examples are listed in Fig. 2. Steroids have
many biological applications due to their non-toxic activity,
bio-availability and less vulnerable to multi-drug resistance
(MDR) [4].
2. Experimental section
2.1. General
The requisite precursors were purchased from Aldrich and
Alfa-Aesar and used as received. The solvents were puriﬁed
and dried as per the literature methods prior to use. The target
molecules were puriﬁed by recrystallization choosing an
appropriate mixture of solvents. The intermediates were puri-
ﬁed by column chromatography using silica gel (60–120 mesh)
as stationary phase. Thin layer chromatography was per-
formed using aluminum sheets pre-coated with silica gel. Melt-
ing points were determined with sigma melting point
apparatus. 1H NMR spectra were recorded using Bruker
(300 MHz) spectrometer. For the 1H NMR spectra, the chem-
ical shifts are reported in ppm relative to SiMe4 as an internal
standard and coupling constants are presented in Hz. Infrared
spectra were recorded on JASCO-FT-IR spectrometer 4000–
400 cm1; the spectral positions are given in wave numbers
(cm1). Electro spray ionization mass spectrometry (ESI-MS)
analysis was performed in the positive ion mode on a liquid
chromatography-ion trap mass spectrometer (LCQ Fleet,
Thermo Fisher Instruments Limited, US).
2.2. General procedure for the synthesis of cholesterylbromo
alkyl derivatives (1)
A mixture of n-bromoalkanoic acid (0.5 mmol), cholesterol
(1.5 mmol), N-N0-dicyclohexylcarbodiimide (DCC) (2 equiv.)O
N
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R1
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Figure 1 Some Schiand a catalytic amount of 4-dimethylaminopyridine (DMAP)
in dry dichloromethane was stirred overnight at room temper-
ature. The reaction mixture was ﬁltered to remove the insolu-
ble material, the ﬁltrate collected and the solvent removed
under reduced pressure. The resulting mixture was puriﬁed
by column chromatography (silica) using dichloromethane as
eluent. The crude product was recrystallized twice from a mix-
ture of chloroform and ethanol [10].
2.3. General procedure for the synthesis of cholesteryl aldehyde
derivatives (2)
A mixture of 4-hydroxy benzaldehyde (3.3 mmol), cholesterol
bromoalkyl derivatives 1 (2.9 mmol) and K2CO3 (3 g) in
10 ml of butanone was heated under reﬂux for 12 h. After
removal of the solvent, 25 ml of water was added to the residue
and the mixture was extracted with chloroform. The organic
layer was washed with water (2 · 15 ml) and dried over Na2-
SO4. The residue obtained after removing the solvent was sub-
jected to column chromatography over silica gel using
petroleum ether/ethyl acetate (19:1) as eluent to get the prod-
uct [22].
2.4. Synthesis of cholesteryl-3-(n-((E)-(40-cyanobiphenyl-4-
ylimino)methyl)-phenoxy or 3-hydroxyphenoxy)alkanoates
The target compounds (3a–3j) were synthesized by the classical
condensation of aldehyde and aniline, with the reaction path
shown in Scheme 1. The equal mole ratio of cholesterol alde-
hyde derivatives 2 and 40-aminobiphenyl-4-carbonilide were
dissolved in ethanol. The reaction mixture was stirred under
reﬂux to give an orange solution. After allowing the solution
to stand in cold condition, yellow solid was collected, washed
with cold ethanol and recrystallized from absolute ethanol to
yield a pure product. All the synthesized compounds were pre-
pared by using the same procedure and shown in Scheme 1.
The structural conﬁrmations were done by using 1H NMR,
13C NMR, EI mass, IR spectra and given as Supplementary
information.
2.5. Cholesteryl-4-(4-((E)-(4’-cyanobiphenyl-4-ylimino)
methyl) phenoxy) butanoate (3a)
Light yellow solid;Mp: 260 C; Y= 93%; IR max (KBr): 2934,
2156, 1720, 1594, 1246, 1164, 824, 726, 546 cm1;1H NMR
(300 MHz, CDCl3) d= 8.42 (s, 1H, N‚CH), 7.85 (d,
J= 9.0 Hz, 2H, ArH), 7.73–7.67 (m, 4H, ArH), 7.61
(d, J= 9.0 Hz, 2H), 7.28 (d, J= 9.0 Hz, 2H, ArH), 6.96 (d,
J= 9.0 Hz, 2H, ArH), 5.4 (d, J= 6.0 Hz, 1H, oleﬁnic H),
4.69–4.53 (m, 1H, CHOCO), 4.07 (t, 2H, J= 6.6 Hz,
OCH2), 2.53–2.48(m, 2H, CH2), 2.34–2.30 (m, 2H, CH2),N
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Figure 2 Some steroid examples.
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Scheme 1 Reagents and conditions: (a) DCC, DMAP, DCM, (b) anhyd K2CO3, KI, butanone reﬂux, 12 h and (c) ethanol, AcOH
(catalytic), refux, 2 h.
S324 M. Kumar et al.2.14–0.85 (m, 42H, CH2), 0.67 (s, 3H,CH3);
13C NMR
(75 MHz, CDCl3) d= 172.5, 161.8, 160.0, 152.3, 145.1,
139.6, 136.1, 132.6, 130.7, 129.1, 127.9, 127.3, 122.7, 121.7,
118.9, 114.7, 110.6, 74.1, 67.0, 56.7, 56.1, 50.0, 42.3, 39.5,
36.6, 36.2, 35.8, 31.9, 31.8, 28.2, 28.0, 23.8, 22.8, 22.6, 19.3,
18.7, 11.8; Ms:m/z 754.417 (M+1).
2.6. Cholesteryl-4-(4-((E)-(4’-cyanobiphenyl-4-ylimino)
methyl)-3-hydroxyphenoxy)butanoate (3b)
Yellow solid; Mp: 264 C; Y= 94%; IR max (KBr): 3390,
2936, 2226, 1728, 1598, 1258, 1164, 824, 726, 546 cm1; 1H
NMR (300 MHz, CDCl3) d= 13.63 (s, 1H, ArOH), 8.59
(s, 1H, N‚CH), 7.74–7.70 (m,4H, ArH), 7.67 (d,
J= 6.0 Hz, 2H, ArH), 7.37 (d, J= 6.0 Hz, 2H, ArH),
7.32 (d, J= 6.0 Hz, 2H, ArH), 6.59 (d, J= 6.0 Hz, 1H)
5.46 (d, 1H, oleﬁnic H), 4.69–4.53 (m 1H, CHOCO), 4.03
(t, 2H, J= 6.6 Hz, OCH2), 2.36–2.29 (m, 4H, CH2), 2.38–
0.94 (m, 49H, –CH2), 0.76 (s, 3H, CH3);
13C NMR
(75 MHz, CDCl3) d= 172.9, 161.8, 159.5, 148.8, 141.8,
139.6, 138.3, 133.7, 132.6, 128.1, 127.4, 122.6, 121.76,
118.8, 118.1, 112.94, 107.74, 106.3, 101.5, 73.8, 67.8, 56.6,
56.1, 49.9, 42.2, 39.6, 39.4, 36.5, 36.7, 31.8, 27.9, 27.8,
22.7, 22.5, 20.9, 18.6, 68.1, 11.8; Ms: m/z 770.667 (M+1).2.7. Cholesteryl-5-(4-((E)-(40-cyanobiphenyl-4-ylimino)
methyl)phenoxy) pentanoate (3c)
Pale yellow solid; Mp: 264 C; Y= 93%; IR max (KBr): 2937,
2256, 1728, 1593, 1246, 1164, 824, 726, 546 cm1; 1H NMR
(300 MHz, CDCl3) d= 8.42 (s, 1H, N‚CH), 7.87 (d,
J= 9.0 Hz, 2H, ArH), 7.75–7.69 (m, 4H, ArH), 7.61 (d,
J= 9.0 Hz, 2H, ArH), 7.29 (d, J= 9.0 Hz, 2H, ArH), 6.99
(d, J= 9.0 Hz, 2H, ArH), 5.38 (d, J= 6.0 Hz, 1H, oleﬁnic
H), 4.67–4.57 (m, 1H, CHOCO), 4.06 (t, 2H, J= 6.6 Hz,
OCH2), 2.39–2.30 (m, 4H, CH2), 2.03–0.86 (m, 42H, CH2),
0.68 (s, 3H, CH3).
13C NMR (75 MHz, CDCl3) d= 172.6,
161.9, 160.0, 152.9, 145.2, 139.6, 136.1, 132.5, 130.6, 129.1,
127.9, 127.3, 122.6, 118.8, 114.8, 110.7, 73.9, 67.7, 56.7, 56.2,
50.1, 42.3, 39.8, 39.5, 38.2, 37.0, 36.6, 36.2, 35.7, 34.2, 31.9,
28.5, 28.2, 27.9, 27.8, 24.2, 23.8, 22.7, 22.5, 21.7, 21.0, 19.3,
18.7, 11.8; Ms: m/z 768.333 (M+1).2.8. Cholesteryl-5-(4-((E)-(40-cyanobiphenyl-4-ylimino)
methyl)-3-hydroxyphenoxy)pentanoate (3d)
Yellow solid; Mp: 267 C; Y= 94%; IR max (KBr): 3391 2936,
2252, 1736, 1556, 1248, 1164, 824, 726, 546 cm1; 1H NMR
Synthesis, characterization and antioxidant activities of Schiff bases are of cholesterol S325(300 MHz, CDCl3) d= 13.59 (s, 1H, ArOH), 8.57 (s, 1H,
N‚CH), 7.74–7.62 (m, 4H, ArH), 7.62 (d, J= 6.0 Hz, 2H,
ArH), 7.37 (d, J= 6.0 Hz, 2H, ArH) 7.34 (d, J= 6.0 Hz,
2H, ArH) 6.46 (d, J= 8.7 Hz, 1H, ArH), 5.36 (d,
J= 6.0 Hz, 1H, oleﬁnic H), 4.63–4.57 (m, 1H, CHOCO),
4.15 (t, J= 6.6 Hz, 2H, OCH2), 2.38–2.30 (m, 4H, CH2),
1.97–0.84 (m, 51H, CH2), 0.7 (s, 3H, CH3).
13C NMR
(75 MHz, CDCl3) d= 172.7, 163.8, 163.6, 161.8, 144.8,
139.6, 136.9, 133.6, 132.6, 128.1, 127.4, 122.6, 121.7, 118.8,
122.9, 110.8, 107.7, 101.6, 73.9, 67.6, 56.6, 56.1, 49.9, 42.2,
39.4, 38.1, 36.6, 35.7, 31.8, 28.1, 27.98, 22.7, 22.5, 21.6, 19.2,
18.6, 11.8; Ms: m/z 784.667 (M+1).
2.9. Cholesteryl-6-(4-((E)-(40-cyanobiphenyl-4-ylimino)
methyl)phenoxy)hexanoate (3e)
Pale yellow solid; Mp: 266 C; Y= 93%; IR max (KBr): 2936,
2252, 1736, 1556, 1248, 1164, 824, 726, 546 cm1; 1H NMR
(300 MHz, CDCl3) d= 8.42 (s, 1H, N‚CH), 7.84 (d,
J= 8.1 Hz, 2H, ArH), 7.77–7.68 (m, 4H, ArH), 7.60 (d,
J= 9.0 Hz, 2H), 7.28 (d, J= 9.0 Hz, 1H, ArH), 6.96 (d,
J= 9.0 Hz, 2H, ArH), 5.37 (d, J= 6.0 Hz, 1H, oleﬁnic H),
4.64–4.57 (m, 1H, CHOCO), 4.03 (t, 2H, J= 6.6 Hz,
OCH2), 2.36–2.31 (m, 4H, CH2), 1.87–0.86 (m, 53H, –CH2),
0.67 (s, 3H, –CH3);
13C NMR (75 MHz, CDCl3) d= 172.9,
161.8, 160.0,152.7, 145.0, 139.6, 136.0, 133.5, 132.6, 128.2,
127.4, 127.3, 122.6, 121.83, 118.9, 113.0, 111.2, 107.8, 101.6,
73.8, 67.9, 56.7, 56.1, 49.9, 42.3, 39.6, 39.4, 36.9,36.5, 35.7,
34.4, 31.9, 28.7, 27.1, 25.5, 24.7, 24.2, 23.7, 22.7, 22.5, 20.9,
19.1, 18.6, 11.8; Ms: m/z 781.667 (M+1).
2.10. Cholesteryl-6-(4-((E)-(40-cyanobiphenyl-4-ylimino)
methyl)-3-hydroxyphenoxy)hexanoate (3f)
Yellow solid;Mp: 269 C; Y= 94%; IR max (KBr): 3397, 2936,
2252, 1736, 1556, 1248, 1164, 824, 726, 546 cm1; 1H NMR
(300 MHz, CDCl3) d= 13.58 (s, 1H, –OH), 8.58 (s, 1H,
N‚CH), 7.75–7.69 (m, 4H, ArH), 7.64 (d, J= 6.0 Hz, 2H,
ArH), 7.37 (d, J= 6.0 Hz, 2H, ArH), 7.27 (s, 1H, ArH),
6.46 (d, J= 6.0 Hz, 2H, ArH), 5.37 (d, J= 6.0 Hz, 1H, ole-
ﬁnic H), 4.69–4.53 (m, 1H, CHOCO), 3.98 (t, 2H,
J= 6.6 Hz, –OCH2), 2.35–2.31 (m, 4H, CH2), 1.82–0.84 (m,
53H, –CH2), 0.66 (s, 3H, CH3);
13C NMR (75 MHz, CDCl3)
d= 173.0, 161.8, 159.5, 148.9, 141.9, 139.6, 138.5, 133.7,
132.6, 128.2, 127.4, 122.6, 121.7, 118.9,118.1, 112.9, 113.0,
111.2, 107.8,106.6, 101.5, 73.8, 67.96, 56.6, 56.1, 50.0, 42.3,
39.6, 39.4,38.1, 36.6, 36.5,35.8,34.5, 31.9, 28.0, 27.8,25.5,24.2,
23.8, 22.7, 22.5, 21.0,19.2, 18.2, 11.8;Ms: m/z 797.667 (M+1).
2.11. Cholesteryl-8-(4-((E)-(40-cyanobiphenyl-4-ylimino)
methyl)phenoxy)octanoate (3g)
Light yellow solid;Mp: 268 C; Y= 93%; IR max (KBr): 2936,
2252, 1736, 1556, 1248, 1164, 824, 726, 546 cm1; 1H NMR
(300 MHz, CDCl3) d= 8.41 (s, 1H, N‚CH), 7.82 (d,
J= 9.0 Hz, 2H, ArH), 7.75 (m, 4H, ArH), 7.59 (d,
J= 9.0 Hz, 2H, ArH), 7.27 (d, J= 9.0 Hz, 2H, ArH), 6.95
(d, J= 9.0 Hz, 2H, ArH), 5.36 (d, J= 6.0 Hz, 1H, oleﬁnic
H), 4.69–4.53 (m, 1H, CHOCO), 4.00 (t, 2H, J= 6.6 Hz,
ArOCH2), 2.33–2.27 (m, 4H, –CH2), 2.25–0.84 (m, 57H, –CH2), 0.66 (s, 3H, –CH3).
13C NMR (300 MHz, CDCl3)
d= 172.3, 161.4, 159.8, 152.8, 152.7, 145.0, 139.5, 135.9,
132.5, 130.6, 129.0, 127.9, 127.2, 122.6, 121.6, 118.9, 114.6,
110.5, 74.2, 67.1, 56.8, 56.2, 50.2, 42.4, 39.6, 36.7, 35.9, 32.0,
31.9, 28.1, 28.1, 23.9, 22.9, 22.7, 19.4, 18.8, 11.9; Ms: m/z
810.667 (M+1).
2.12. Cholesteryl-8-(4-((E)-(40-cyanobiphenyl-4-ylimino)
methyl)-3-hydroxyphenoxy)octanoate (3h)
Yellow solid;Mp: 273 C; Y= 94%; IR max (KBr): 3396, 2936,
2252, 1736, 1556, 1248, 1164, 824, 726, 546 cm1; 1H NMR
(300 MHz, CDCl3) d= 13.62 (s,1H, ArOH) 8.58 (s, 1H,
N‚CH), 7.74–7.70 (m, 4H, ArH) 7.63 (d, J= 6.0 Hz, 2H,
ArH), 7.H, 7.27 (s, 1H, ArH), 6.41 (d, J= 6.0 Hz, 2H,
ArH), 5.38 (d, J= 6.0 Hz, 1H, oleﬁnic H), 4.65–4.59 (m,
1H, CHOCO), 3.90 (t, 2H, J= 6.6 Hz, ArOCH2), 2.32–2.28
(m, 4H, CH2), 2.25–0.84 (m, 57H, –CH2), 0.66 (s, 3H, –
CH3).
13C NMR (75 MHz, CDCl3) d= 173.00, 161.87,
159.62, 148.91, 141.90, 139.69, 138.42, 133.76, 132.69, 128.26,
127.47, 122.67, 121.83, 118.93, 113.01, 111.22, 107.82, 101.65,
73.88, 67.96, 56.72, 56.17, 50.06, 42.35, 39.77, 39.56, 36.64,
35.83, 31.90, 28.04, 27.87, 22.86, 22.61, 21.06, 18.76, 11.89;
Ms: m/z 826.667 (M+1).
2.13. Cholesteryl-10-(4-((E)-(40-cyanobiphenyl-4-ylimino)
methyl)phenoxy)decanoate (3i)
Pale yellow solid; Mp: 271 C; Y= 93%; IR max (KBr): 2936,
2252, 1736, 1556, 1248, 1164, 824, 726, 546 cm1; 1H NMR
(300 MHz, CDCl3) d= 8.43 (s, 1H, N‚CH), 7.85 (d,
J= 8.1 Hz, 2H, ArH), 7.75–7.70 (m, 4H, ArH), 7.62 (d,
J= 8.4 Hz, 2H), 7.30 (d, J= 8.4 Hz, 2H, ArH), 6.98 (d,
J= 8.7 Hz, 2H, ArH), 5.37 (d, J= 6.0 Hz, 1H, oleﬁnic H),
4.61–4.56 (m, 1H, CHOCO), 4.02 (t, 2H, J= 6.6 Hz,
ArOCH2), 2.33 (m, 4H, CH2), 2.26–0.86 (m, 63H, -aliphatic
H), 0.68 (s, 3H, CH3);
13C NMR (75 MHz, CDCl3)
d= 173.2, 162.1, 160.0, 152.8, 145.0, 139.6, 136.0, 132.5,
130.6, 128.8, 127.9, 127.3, 122.5, 121.6, 118.9, 114.7, 110.5,
73.6, 68.2, 56.6, 56.1, 50.0, 42.2, 39.5,39.4, 38.1, 36.56, 31.8,
29.4, 29.3, 29.2, 29.1, 29.0, 27.9, 24.4, 23.7, 22.7, 22.5,20.9,
19.2, 18.6, 11.7; Ms: m/z 852.227 (M+1).
2.14. Cholesteryl-10-(4-((E)-(40-cyanobiphenyl-4-ylimino)
methyl)-3-hydroxyphenoxy)decanoate (3j)
Yellow solid; Mp: 260 C; Y= 94%; IR max (KBr): 3397,
2936, 2252, 1736, 1556, 1248, 1164, 824, 726, 546 cm1; 1H
NMR (300 MHz, CDCl3) d= 13.70 (s, 1H, –OH), 8.67 (s,
1H, N‚CH), 7.81–7.72 (m, 6H, ArH), 7.84–7.77 (m, 4H,
ArH), 7.72 (d, J= 6.0 Hz, 2H, ArH), 7.42 (d, J= 6.0 Hz,
2H, ArH), 7.39 (s, 1H, ArH) 5.45 (d, J= 6.0 Hz, 1H, ole-
ﬁnic H), 4.74–4.64 (m, 1H, CHOCO), 4.09 (t, 2H,
J= 6.6 Hz, OCH2), 2.35–2.33 (m, 4H, CH2), 1.95–0.93 (m,
66H, CH2), 0.75 (s, 3H, CH3);
13C NMR (75 MHz, CDCl3)
d= 173.0, 161.8, 159.6, 148.9, 141.9, 139.6, 138.4, 133.7,
132.6, 128.2, 127.4, 122.6, 121.8, 118.2, 113.0, 107.8, 106.4,
101.6, 73.8, 67.9, 65.3, 56.7, 56.1, 50.0, 42.3, 39.7, 39.5,
36.6, 35.8, 31.9, 28.0, 23.8, 22.6, 21.06, 18.7, 11.8; Ms: m/z
867.579 (M+1).
Table 1 Antioxidant activity of cholesterol derivatives (3a–j)
and vitamin C against various radicals.
Compound IC50 (lM)
DPPH SO NO H2O2
Vitamin C 32.50 52.00 55.00 43.00
3a 15.48 29.08 32.33 26.69
3b 12.53 27.82 29.61 25.25
3c 16.76 31.06 30.00 30.17
3d 13.75 30.12 31.25 28.00
3e 15.18 36.07 32.25 25.28
3f 14.00 32.88 28.65 24.20
3g 15.51 28.72 27.32 26.40
3h 14.83 32.91 25.62 25.88
3i 15.71 33.42 31.48 29.46
3j 13.90 35.82 29.34 26.76
S326 M. Kumar et al.2.15. Antioxidant assays
The ability of cholesterol derivatives as a free radical scavenger
was explored by conducting a series of in vitro antioxidant
assays involving DPPH radical, hydroxyl radical, nitric oxide
radical, hydrogen peroxide, superoxide anion radical and com-
paring the results with standard antioxidant vitamin C. The
DPPH radical scavenging activity of the compounds was mea-
sured according to the method of Blios [7,19]. The assay of
nitric oxide (NO) scavenging activity was carried out based
on the method reported by Green [12]. The ability of the com-
pounds to scavenge hydrogen peroxide was determined using
the method available in the literature [29]. The sueroxide anion
radical (O2
) scavenging assay was based on the capacity of the
complexes to inhibit formazan formation by scavenging the
superoxide radicals generated in the riboﬂavin-light-NBT sys-
tem [6].3. Results and discussion
3.1. Synthesis
The target cholesterol derivatives (3a–j) were synthesized as
depicted in Scheme 1. Initially the cholesterol aldehyde deriv-
atives were prepared by Williamson ether synthesis. The target
compound can be prepared by acid catalyzed condensation of
cholesterol aldehyde derivatives and 40-aminobiphenyl-4-car-
bonitrile in ethanol, then it was reﬂuxed for 3 h. The product
was formed by cooling and it was puriﬁed by recrystallization
with ethanol.
The target compounds (3a–j) were synthesized by the clas-
sical condensation of aldehyde and aniline as depicted in
Scheme 1. The equal mole ratio of cholesterol aldehyde deriv-
atives and 40-aminobiphenyl-4-carbonilide was dissolved in
ethanol. The reaction mixture was stirred under reﬂux to give
an orange color solution. After allowing the solution to stand
in cold condition, yellow solid was collected, washed with cold
ethanol and recrystallized from ethanol. All the synthesized
compounds were prepared by the same procedure. The struc-
tures were conﬁrmed by using 1H NMR, 13C NMR, EI mass,
IR spectra and given as Supplementary information.
3.2. Spectrophotometric determination of DPPH radical
scavenging activity
Most of the investigations are taken as DPPH assay to evalu-
ate the antioxidant activity of their targets due to its simple
procedure and reliability. The results of the DPPH radical
scavenging activity of the compounds are shown in Table 1.
Lower IC50 value reﬂects better DPPH radical-scavenging
activity. From the table, it was clear that almost all the com-
pounds showed radical scavenging activities in DPPH assay.
It was important to note that compounds 3b, 3d and 3j have
shown better antioxidant activity than vitamin C with IC50 val-
ues 12.53, 13.75 and 13.90 lM respectively. The DPPH activ-
ities of the tested compounds were found to be in the
decreasing order of 3b, 3d, 3j, 3f, 3h, 3e, 3a, 3g, 3i and 3c.
The presence of Schiff base and –OH groups also has inﬂuenceon the DPPH radical scavenging activity and ethylene spacer
does not have any effect on antioxidant property.
3.3. Superoxide anion radical scavenging assay
The results of O2
 assay were expressed as IC50 values as
shown in Table 1 revealed that compounds 3b, 3g, 3a and 3d
showed better superoxide anion radical scavenging activity
than natural antioxidant vitamin C with IC50 of 29.08, 27.82,
28.72 and 27.91 lM respectively. Surprisingly IC50 values of
all synthesized compounds were lower than IC50 of vitamin
C. The super oxide anion radical scavenging activities were
found to be in the order of 3b, 3g, 3a, 3d, 3c, 3f, 3h, 3i, 3j
and 3e.
3.4. Nitric oxide radical scavenging assay
In general scavenging studies, this radical is very essential.
Reactive species are responsible for altering the structural
and functional behavior of many cellular compounds. The
results of the NO assay expressed as IC50 values as shown
in Table 1 revealed that compounds 3h, 3g, 3f, 3j and 3b have
shown better nitric oxide radical scavenging activity than nat-
ural antioxidant vitamin C with IC50 of 25.62, 27.32, 28.65,
29.34 and 29.61 lM respectively. Surprisingly IC50 values of
all synthesized compounds were lower than IC50 of vitamin
C. The nitric oxide radical scavenging activities of the tested
compounds were found to be in the decreasing order of 3h,
3g, 3f, 3j, 3b, 3c, 3d, 3i, 3e, 3a and vitamin C.
3.5. H2O2 scavenging assay
Hydrogen peroxide is not very reactive itself, but it can cross
the cell membrane and produce the hydroxide radical, which
is highly reactive. The IC50 values of hydrogen peroxide assay
of 3f, 3b, 3e, 3h and 3g have revealed better scavenging poten-
tial than natural antioxidant vitamin C with IC50 of 24.20,
25.25, 25.28, 25.88 and 26.40 lM respectively. The hydrogen
peroxide radical scavenging activities of the tested compounds
found to be in the decreasing order of 3f, 3b, 3e, 3h, 3g, 3a, 3j,
3d, 3i, 3c, and vitamin C.
Synthesis, characterization and antioxidant activities of Schiff bases are of cholesterol S3274. Conclusions
A series of cholesteryl-11-(4-((E)-(40-cyanobiphenyl-4-ylimi-
no)methyl)phenoxy)alkanoate have been synthesized. The
structures were conﬁrmed by 1H NMR, 13C NMR, FT-IR
and mass spectral studies. These compounds exhibited excel-
lent radical scavenging activities against super oxide anion rad-
ical, nitric oxide radical, DPPH radical and hydrogen
peroxide. Of all these targeted compounds 3b, 3d and 3j
showed better antioxidant activity than vitamin C in DPPH
assay; compounds 3b, 3g, 3a and 3d showed better superoxide
anion radical scavenging activity than natural antioxidant vita-
min C; compounds 3h, 3g, 3f, 3i, 3j and 3b showed better nitric
oxide radical scavenging activity than natural antioxidant vita-
min C: compounds 3f, 3b, 3e, 3f, 3h and 3g have revealed that
they have better hydrogen peroxide scavenging potential than
natural antioxidant vitamin C. Based on the result, it is clear
that these compounds can be used as good antioxidants in
the ﬁeld of medicinal and food industry.
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